The contribution of pharmacogenetics to pharmacovigilance.
Bondon-Guitton, Emmanuelle
The contribution of pharmacogenetics to pharmacovigilance. [electronic resource] - Therapie Apr 2016 - 223-8 p. digital
Publication Type: Journal Article
0040-5957
10.1016/j.therap.2016.02.005 doi
Antineoplastic Agents--adverse effects
Cytochrome P-450 Enzyme System--genetics
Dideoxynucleosides--adverse effects
Drug Hypersensitivity--genetics
Drug Overdose--epidemiology
Drug-Related Side Effects and Adverse Reactions--epidemiology
Humans
Pharmacogenetics--methods
Pharmacovigilance
The contribution of pharmacogenetics to pharmacovigilance. [electronic resource] - Therapie Apr 2016 - 223-8 p. digital
Publication Type: Journal Article
0040-5957
10.1016/j.therap.2016.02.005 doi
Antineoplastic Agents--adverse effects
Cytochrome P-450 Enzyme System--genetics
Dideoxynucleosides--adverse effects
Drug Hypersensitivity--genetics
Drug Overdose--epidemiology
Drug-Related Side Effects and Adverse Reactions--epidemiology
Humans
Pharmacogenetics--methods
Pharmacovigilance